4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-22-002294
Options or other derivatives
- CHIEF EXECUTIVE OFFICER acquired 300,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Singh Shawn CHIEF EXECUTIVE OFFICER | 2022-03-01 | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | D | ||
Loading xslF345X03/form4-03032022_010311.xml…